×
Cencora Inventory 2010-2024 | COR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Cencora inventory for the quarter ending December 31, 2024 was
$20.508B
, a
9.95% increase
year-over-year.
Cencora inventory for 2024 was
$18.999B
, a
8.85% increase
from 2023.
Cencora inventory for 2023 was
$17.455B
, a
12.2% increase
from 2022.
Cencora inventory for 2022 was
$15.556B
, a
1.22% increase
from 2021.
View More
Cencora Inventory 2010-2024 | COR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Cencora inventory for 2024 was
$18.999B
, a
8.85% increase
from 2023.
Cencora inventory for 2023 was
$17.455B
, a
12.2% increase
from 2022.
Cencora inventory for 2022 was
$15.556B
, a
1.22% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$150.2B
Elevance Health (ELV)
$90.6B
CVS Health (CVS)
$82.1B
DiDi Global (DIDIY)
$23.3B
Natera (NTRA)
$22.2B
ICON (ICLR)
$16.7B
BioMerieux (BMXMF)
$14.1B
Doximity (DOCS)
$14B
Revvity (RVTY)
$14B
Viatris (VTRS)
$13.2B
Solventum (SOLV)
$12.9B
Avantor (AVTR)
$11.9B
CochLear (CHEOY)
$11.3B
Medpace Holdings (MEDP)
$10.5B
EUROFINS SCIENT (ERFSF)
$9.8B
HealthEquity (HQY)
$9.7B
Sonic Healthcare (SKHHY)
$8.7B
Charles River Laboratories (CRL)
$8.3B
Amplifon S.p.A (AMFPF)
$6.2B
Bausch + Lomb (BLCO)
$5.6B
Organon (OGN)
$4B
Sotera Health (SHC)
$3.8B
BrightSpring Health Services (BTSG)
$3.6B
Surgery Partners (SGRY)
$3.3B
Concentras Parent (CON)
$3B
GeneDx Holdings (WGS)
$2.8B
Alignment Healthcare (ALHC)
$2.8B
Teladoc Health (TDOC)
$2.2B
Ardent Health Partners (ARDT)
$2.1B
Progyny (PGNY)
$2B